Mock injection

OTHER2 trials

Sponsors

jCyte, Inc

Conditions

Retinitis Pigmentosa

Phase 2

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

CompletedNCT03073733

jCyte, IncRetinitis Pigmentosa

Start: 2017-03-01End: 2020-11-13Updated: 2024-06-18

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Active, not recruitingNCT06912633

jCyte, IncRetinitis Pigmentosa

Start: 2025-06-20End: 2026-12-01Updated: 2026-07-30

Related Papers

GMP-grade human neural progenitors delivered subretinally protect vision in rat model of retinal degeneration and survive in minipigs.

2023-09-256 citations